Cancer Associated Thrombosis, a Pilot Treatment Study Using Rivaroxaban

NCT02746185 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

159

Enrollment

OTHER

Sponsor class

Conditions

Neoplasm
Venous Thromboembolism

Interventions

DRUG: rivaroxaban
DRUG: Low-molecular-weight heparin

Sponsor

Assistance Publique - Hôpitaux de Paris

Collaborators

[object Object]